Perspectives

Building Better Patient Care in Mississippi Radiation Oncology: Why Mississippi Needs a Collaborative Quality Initiative

Authors: William N. Duggar, PhD, Paul R. Roberts, MD, Toms V. Thomas, MD, Caleb Dulaney, MD

Abstract

Objectives: Cancer is an insidious and devastating disease that affects many people. Progress in mortality rate has not been realized universally across the United States, and challenges remain in how to best make up the ground that has been lost in these areas, one of which is Mississippi. Radiation therapy is a significant contributor to cancer control rates and certain challenges exist specifically regarding this treatment modality.

Methods: The challenges of radiation oncology in Mississippi have been reviewed and discussed, with the proposal of a potential collaboration between clinical practitioners and payors to provide optimal and cost-effective radiation therapy to patients in Mississippi.

Results: A similar model to that proposed has been reviewed and evaluated. This model is discussed based on its potential validity and usefulness in Mississippi.

Conclusions: Significant barriers exist in the state of Mississippi to patients receiving a consistent standard of care, regardless of their location and socioeconomic status. A collaborative quality initiative has been shown to be a boon to this endeavor elsewhere and stands to have a similar impact in Mississippi.
Posted in: Medical Oncology46

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. American Cancer Society. Cancer Statistics Center, 2021 estimates. https://cancerstatisticscenter.cancer.org/#!/. Accessed July 23, 2021.
 
2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin 2020;70:7–30.
 
3. Bates JE, Parekh AD, Chowdhary M, et al. Geographic distribution of radiation oncologists in the United States. Pract Radiat Oncol 2020;10: e436–e443.
 
4. Bates JE, Thaker NG, Parekh A, et al. Geographic access to brachytherapy services in the United States. Brachytherapy 2022;21:29–32.
 
5. Maroongroge S, Wallington DG, Taylor PA, et al. Geographic access to radiation therapy facilities in the United States. Int J Radiat Oncol Biol Phys 2022;112:600–610.
 
6. Chowdhary M, Chhabra AM, Switchenko JM, et al. Domestic job shortage or job maldistribution? A geographic analysis of the current radiation oncology job market. Int J Radiat Oncol Biol Phys 2017;99:9–15.
 
7. Bloom DE, Bowser DM. The population health and income nexus in the Mississippi River Delta region and beyond. J Health Hum Serv Admin 2008;31:105–123.
 
8. Cossman RE, Cossman JS, Rogers S, et al. Access to primary care physicians differs by health insurance coverage in Mississippi. South Med J 2014;107: 87–90.
 
9. Yabroff KR, Reeder-Hayes K, Zhao J, et al. Health insurance coverage disruptions and cancer care and outcomes: systematic review of published research. J Natl Cancer Inst 2020;112:671–687.
 
10. Zhao G, Okoro CA, Dhingra SS, et al. Trends of lack of health insurance among US adults aged 18–64 years: findings from the Behavioral Risk Factor Surveillance System, 1993–2014. Public Health 2017;146:108–117.
 
11. Boyce-Fappiano D, Nguyen KA, Gjyshi O, et al. Socioeconomic and racial determinants of brachytherapy utilization for cervical cancer: concerns for widening disparities. JCO Oncol Pract 2021;17:e1958–e1967.
 
12. Colevas AD, Yom SS, Pfister DG, et al. NCCN guidelines insights: head and neck cancers, version 1.2018. J Natl Compr Canc Netw 2018;16:479–490.
 
13. Faruque FS, Zhang X, Nichols EN, et al. The impact of preventive screening resource distribution on geographic and population-based disparities in colorectal cancer in Mississippi. BMC Res Notes 2015;8:423.
 
14. Michigan Blue Cross Blue Shield. Value partnerships. https://www.valuepartnerships.com/. Accessed July 16, 2021.
 
15. Michigan Radiation Oncology Quality Consortium. About. https://mroqc.org/about. Accessed July 16, 2021.
 
16. Moran JM, Feng M, Benedetti LA, et al. Development of a model web-based system to support a statewide quality consortium in radiation oncology. Pract Radiat Oncol 2017;7:e205–e213.
 
17. Dess RT, Sun Y, Muenz DG, et al. Cardiac dose in locally advanced lung cancer: results from a statewide consortium. Pract Radiat Oncol 2020;10: e27–e36.
 
v18. Jagsi R, Griffith KA, Heimburger D, et al. Choosing wisely? Patterns and correlates of the use of hypofractionated whole-breast radiation therapy in the state of Michigan. Int J Radiat Oncol Biol Phys 2014;90:1010–1016.
 
19. Jagsi R, Griffith KA, Boike TP, et al. Differences in the acute toxic effects of breast radiotherapy by fractionation schedule: comparative analysis of physician-assessed and patient-reported outcomes in a large multicenter cohort. JAMA Oncol 2015;1:918–930.
 
20. Jaworski EM, Yin H, Griffith KA, et al. Contemporary practice patterns for palliative radiation therapy of bone metastases: impact of a quality improvement project on extended fractionation. Pract Radiat Oncol 2021; 11:e498–e505.
 
21. Laucis AM, Jagsi R, Griffith KA, et al. The role of facility variation on racial disparities in use of hypofractionated whole breast radiation therapy. Int J Radiat Oncol Biol Phys 2020;107:949–958.
 
22. Matuszak MM, Paximadis P, Yudelev M, et al. Managing motion in conventionally fractionated lung cancer radiation therapy: collaborative quality improvement from a statewide consortium of academic and community practices. Pract Radiat Oncol 2018;8:e208–e211.
 
23. Pierce LJ, Feng M, Griffith KA, et al. Recent time trends and predictors of heart dose from breast radiation therapy in a large quality consortium of radiation oncology practices. Int J Radiat Oncol Biol Phys 2017;99: 1154–1161.
 
24. Spratt DE, Mancini BR, Hayman JA, et al. Contemporary statewide practice pattern assessment of the palliative treatment of bone metastasis. Int J Radiat Oncol Biol Phys 2018;101:462–467.
 
25. Paximadis P, Schipper M, Matuszak M, et al. Dosimetric predictors for acute esophagitis during radiation therapy for lung cancer: results of a large statewide observational study. Pract Radiat Oncol 2018;8:167–173.
 
26. Jagsi R, Griffith KA, Vicini F, et al. Toward improving patients' experiences of acute toxicity from breast radiotherapy: insights from the analysis of patient-reported outcomes in a large multicenter cohort. J Clin Oncol 2020; 38:4019.
 
27. Blue Cross Blue Shield Association. Blue Distinction centers for cancer care. Selection criteria. https://www.bcbs.com/sites/default/files/file-attachments/page/Cancer.Care_.Selection.Criteria.pdf. Published December 12, 2016. Accessed December 2, 2022.
 
28. Blue Cross Blue Shield of Mississippi. Home page. https://www.bcbsms.com/. Accessed December 2, 2022.